Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
10-Q
Rhea-AI Filing Summary
Balance Labs, Inc. reported minimal operating scale for the quarter ended June 30, 2026. The company generated $7,333 in quarterly consulting revenue and $40,000 for the six months, but incurred operating expenses of $1,028,644, leading to a loss from operations of $988,644 for the first half of 2026.
A large non-cash gain of $982,505 from remeasurement of a derivative liability tied to the CEO’s anti-dilution right reduced the six‑month net loss to $59,038. However, the balance sheet remains highly stressed, with cash of only $117,465, total assets of $126,771, total liabilities of $2,900,185, and a stockholders’ deficit of $2,773,414 as of June 30, 2026.
Management discloses substantial doubt about the company’s ability to continue as a going concern, citing a working capital deficit of $2,773,414, accumulated deficit of $37,710,684, and defaulted debt, including a $25,000 convertible note and related-party notes totaling $500,000. Internal controls over financial reporting are described as ineffective, with material weaknesses in formal controls, audit committee oversight, and segregation of duties. A subsequent $20,000‑per‑month consulting contract beginning July 2026 modestly enhances prospective revenue but does not resolve the liquidity challenge.
Positive
- None.
Negative
- Going-concern warning driven by only $117,465 cash and a $2,773,414 working capital deficit, creating substantial doubt about continued operations.
- Debt defaults include a $25,000 convertible note and related-party notes totaling $500,000 plus $79,501 accrued interest, all unpaid at maturity.
- Severe balance-sheet weakness with total assets of $126,771 against liabilities of $2,900,185, resulting in a stockholders’ deficit of $2,773,414.
- Material weaknesses in internal control over financial reporting, including lack of an audit committee and inadequate segregation of duties.
- CEO anti-dilution derivative of $962,301 may cause substantial future dilution and earnings volatility for existing stockholders.
